Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

CONVERTIBLE DEBT AND EQUITY FINANCINGS (Tables)

3 Months Ended

Dec. 31, 2014

		As of December 31, 2014
						Carrying
		Balance		Discount		Value
Note Type and Investor	Due Date	($)		($)		($)
Senior Secured 5% Notes Convertible at $0.25
(the “September 2014 Notes”)

RSJ Private Equity	03/21/2016	$	750,000	$	(56,200)	$	693,800
4 Accredited Investors	03/21/2016		300,000		(24,200)		275,800
John Pappajohn	03/21/2016		200,000		(21,300)		178,700
Tierney Family Trust	03/21/2016		200,000		(21,300)		178,700
Oman Ventures	03/21/2016		200,000		(21,300)		178,700
Total Secured Convertible Promissory (September 2014) Notes		$	1,650,000	$	(144,300)	$	1,505,700